1 Department of Cardiology, Baixo Vouga Hospital Centre, Portugal.
2 CIDMA/IBIMED/Department of Mathematics, University of Aveiro, Portugal.
Eur Heart J Acute Cardiovasc Care. 2018 Oct;7(7):614-623. doi: 10.1177/2048872617706502. Epub 2017 Apr 28.
Patients presenting with spontaneous coronary artery dissection (SCAD) may receive either conservative medical management or a revascularisation strategy. There is still a lack of consensus with respect to the best treatment approach for SCAD.
We sought to determine whether outcomes differ between the first-line treatment approaches (conservative versus revascularisation) in patients with SCAD.
We searched Medline, EMBASE and the Cochrane Library for studies published from January 1990 to November 2016 that compared first-line treatments for patients with SCAD. We conducted a pooled risk ratio meta-analysis for four main outcomes: mortality, myocardial infarction (MI), SCAD recurrence and target vessel revascularisation (TVR).
We identified 11 non-randomised studies that included a total of 631 patients. A pooled meta-analysis showed no significant difference between conservative management and revascularisation approaches in mortality (risk difference [RD] = 0.01; 95% confidence interval [CI] = -0.01 to 0.04; I = 0%; p = 1), MI (RD = -0.01; 95% CI = -0.04 to 0.03; I = 0%; p = 0.5) or SCAD recurrence (RD = -0.01; 95% CI = -0.06 to 0.05; I = 0%; p = 0.74). Revascularisation as an initial first-line approach was associated with an estimated additional risk of TVR of 6.3% (RD = 0.06; 95% CI = 0.01-0.11; I = 0%; p = 0.96).
The results demonstrate an increased risk of TVR when revascularisation was used as the initial first-line treatment approach. The treatment decision must be individualised and be based on both clinical and angiographic factors, but conservative therapy should prevail in most cases.
自发性冠状动脉夹层(SCAD)患者可接受保守的药物治疗或血运重建策略。目前对于 SCAD 的最佳治疗方法仍缺乏共识。
我们旨在确定 SCAD 患者的一线治疗方法(保守与血运重建)之间的结局是否存在差异。
我们检索了从 1990 年 1 月至 2016 年 11 月发表的比较 SCAD 患者一线治疗的 Medline、EMBASE 和 Cochrane 图书馆研究。我们对四项主要结局(死亡率、心肌梗死、SCAD 复发和靶血管血运重建)进行了汇总风险比荟萃分析。
我们确定了 11 项非随机研究,共纳入 631 例患者。汇总荟萃分析显示,在死亡率(风险差异 [RD] = 0.01;95%置信区间 [CI] = -0.01 至 0.04;I = 0%;p = 1)、心肌梗死(RD = -0.01;95%CI = -0.04 至 0.03;I = 0%;p = 0.5)或 SCAD 复发(RD = -0.01;95%CI = -0.06 至 0.05;I = 0%;p = 0.74)方面,保守治疗与血运重建策略之间无显著差异。作为初始一线治疗方法,血运重建与 TVR 的估计额外风险相关,风险比为 6.3%(RD = 0.06;95%CI = 0.01 至 0.11;I = 0%;p = 0.96)。
结果表明,当血运重建作为初始一线治疗方法时,TVR 的风险增加。治疗决策必须个体化,并基于临床和血管造影因素,但在大多数情况下应优先采用保守治疗。